Pneumagen has announced the publication of phase 2 data showing its antiviral therapy, Neumifil, significantly reduced ...

A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...

Phase 2 protocol submitted to HREC to evaluate tivoxavir marboxil (TXM) in a combined seasonal and bird flu study in the Southern Hemisphere Briefing documents submitted to FDA for a Type D meeting ...

New research from the University of Pittsburgh School of Medicine and La Jolla Institute for Immunology, published today in ...

As respiratory illnesses like COVID-19, influenza, and Mycoplasma pneumonia continue to spread, the need for safe, ...

Influenza continues to pose a significant global health burden, with seasonal outbreaks causing substantial morbidity and ...

Cidara Therapeutics has reported encouraging top-line outcomes from the Phase IIb NAVIGATE trial of the investigational drug-Fc conjugate (DFC), CD388, for seasonal influenza prevention in healthy ...

Influenza continues to pose a significant global health burden, with seasonal outbreaks causing substantial morbidity and mortality. Current ...

Shares of Cidada Therapeutics doubled in value on Monday and jumped in after-hours trading as the biotech firm released ...

Company shares doubled on Phase 2 study results suggesting its drug could become an alternative to vaccines for flu ...